Pharmacological Profiles of CS-622, a Novel Angiotensin Converting Enzyme Inhibitor
Authors:
Open Access
- 1 January 1988
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 48 (3) , 349-356
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 9 references indexed in Scilit:
- Angiotensin-converting enzyme inhibitors. Perhydro-1,4-thiazepin-5-one derivativesJournal of Medicinal Chemistry, 1987
- Biological Properties of the Angiotensin-Converting Enzyme Inhibitor CilazaprilJournal of Cardiovascular Pharmacology, 1985
- The Present Molecules of Converting Enzyme InhibitorsJournal of Cardiovascular Pharmacology, 1985
- Elimination kinetics of captopril in patients with renal failureKidney International, 1984
- The physiological disposition and metabolism of enalapril maleate in laboratory animals.Drug Metabolism and Disposition, 1982
- Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.The Journal of Pharmacology and Experimental Therapeutics, 1981
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- Pulmonary angiotensin-converting enzyme. Structural and catalytic properties.Journal of Biological Chemistry, 1975
- Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lungBiochemical Pharmacology, 1971